ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2434

Obstetric Outcomes in Women with Takayasu Arteritis: Results from Nationwide Inpatient Sample Database 2003-2011

Shweta Kishore1, Varun Mittal2 and Vikas Majithia1, 1Division of Rheumatology, University of Mississippi, Jackson, MS, 2University of Mississippi, Jackson, MS

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Pregnancy and takayasu arteritis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, October 23, 2018

Title: Reproductive Issues in Rheumatic Disorders Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Few case reports and series suggest adverse pregnancy outcomes in patients with Takayasu Arteritis (TA). This study was undertaken to determine the frequency of complications occurring during pregnancy for women with TA and to compare these outcomes with the general obstetric population by using the largest inpatient care database.

Methods: By using the 2003-2011 Nationwide Inpatient Sample of Healthcare Cost and Utilization Project, we estimated the number of obstetric hospitalization, deliveries and caesarean deliveries in women between the age group 18-50 years. Patients hospitalized with TA as one of the diagnoses were identified. Demographic characteristics and in-hospital outcomes were recorded for both TA and control group. Then we compared maternal and pregnancy complications for all pregnancy-related admissions for women with and without TA. Multivariate logistic regression analysis was used to obtain adjusted odds ratio (OR).

Results: The total number of obstetric hospitalization was 42.32 million of which 348 were women with diagnosis of TA. The maternal age of TA population was higher (28.1 years) than that in the control group (27 years) (p < 0.001). After adjusting for potential confounders, maternal TA population had a significantly higher prevalence of hypertensive diseases. The prevalence of intrauterine growth retardation, preterm delivery and antepartum hemorrhage was higher in TA population but did not reach a statistical significance. However, the odds of cesarean delivery, premature rupture of membranes and postpartum hemorrhage was lower in TA population. The frequencies of the above outcomes along with Odds Ratio are provided in Table 1.

Conclusion: Based on our study of national cohort, we conclude that women with TA have a higher risk of adverse outcomes of pregnancy than do pregnant women without TA, especially the hypertensive complications. Thus close antenatal and post-delivery monitoring need to be performed in order to reduce complications. The other outcomes did not reach a statistical significance likely due to small number of TA patients. Further studies with larger number of patients are needed to examine these findings. 

References:

    Healthcare cost and utilization project: overview of the Nationwide Inpatient Sample (NIS). URL: http://www.hcup-us.ahrq.gov.

Table 1. Obstetric Outcomes for Pregnancy Related Hospitalizations

Variable

All patients

TA

No TA

OR

P value

No of patients

42317648

348

42317300

NA

Hypertensive diseases

3757992

182(52.3%)

3757810(8.9%)

4.584

(CI 3.352- 6.268)

<0.001

Cesarean Delivery

11857999

78(22.4%)

11857921(28%)

0.592

(CI 0.444-0.789)

<0.001

IUGR

774439

18(5.2%)

774421(1.8%)

1.861

(CI 1.063-3.256)

0.30

Preterm Delivery

2798720

55(15.8%)

2798665(6.6%)

1.227

(CI 0.832-1.809)

0.301

PROM

1456334

24(6.9%)

1456310(3.4%)

0.434

(CI 0.161-1.167)

0.98

Antepartum hemorrhage

8632232

9(2.6%)

863223(2%)

1.479

(CI 0.762-2.871)

0.247

Postpartum Hemorrhage

1106420

10(2.9%)

1106410(2.6%)

0.568

(CI 0.226-1.430)

0.230

Abbreviations: TA= Takayasu Arteritis; PROM= Premature Rupture of Membranes; IUGR= Intrauterine Growth Retardation; OR= Odds Ratio (95% Confidence Interval (CI)); NA= Not Applicable


Disclosure: S. Kishore, None; V. Mittal, None; V. Majithia, None.

To cite this abstract in AMA style:

Kishore S, Mittal V, Majithia V. Obstetric Outcomes in Women with Takayasu Arteritis: Results from Nationwide Inpatient Sample Database 2003-2011 [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/obstetric-outcomes-in-women-with-takayasu-arteritis-results-from-nationwide-inpatient-sample-database-2003-2011/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/obstetric-outcomes-in-women-with-takayasu-arteritis-results-from-nationwide-inpatient-sample-database-2003-2011/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology